2019
Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population‐level analysis
Zeidan AM, Podoltsev NA, Wang X, Bewersdorf JP, Shallis RM, Huntington SF, Gore SD, Davidoff AJ, Ma X, Wang R. Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population‐level analysis. Cancer 2019, 125: 4241-4251. PMID: 31483484, PMCID: PMC7733320, DOI: 10.1002/cncr.32439.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaTime of diagnosisOlder patientsActive treatmentMyeloid leukemiaMultivariable logistic regression modelMedian overall survivalPercentage of patientsLow-intensity therapyMajority of patientsNovel therapeutic optionsQuality of careLogistic regression modelsIntensity therapyTherapy receiptOverall survivalWorse survivalClinical factorsInferior survivalEntire cohortTherapeutic optionsPatient populationRetrospective analysisHigher oddsProvider characteristics
2011
Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients
Podoltsev N, Bustillo I, Yao X, Liu H, Cooper D. Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients. Blood 2011, 118: 4941. DOI: 10.1182/blood.v118.21.4941.4941.Peer-Reviewed Original ResearchReduction of immunosuppressionDiffuse large B-cell lymphomaYale Cancer CenterMonomorphic PTLDPolymorphic PTLDPTLD patientsGraft lossGraft rejectionComplete responseB cellsMedian progression-free survivalSolid organ transplantation recipientsEpstein-Barr virus infectionLarge B-cell lymphomaEBV-negative tumorsGraft loss rateStandard immunosuppressive agentsMedian overall survivalAdvanced stage diseaseConsequence of immunosuppressionEBV-positive lymphomasOrgan transplantation recipientsProgression-free survivalRetrospective cohort trialTime of diagnosis